Newsletter Subject

Stella Immanuel Highest U.S. Prescriber of Ivermectin and HCQ

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Thu, Mar 2, 2023 11:52 PM

Email Preheader Text

Daily Headlines Thursday, March 02, 2023 Today's Top Stories for {NAME} THE BREAK ROOM CME SPOTLIGHT

[MEDPAGE TODAY]( Daily Headlines Thursday, March 02, 2023 Today's Top Stories for {NAME} [SPECIAL REPORTS]( [Stella Immanuel Highest U.S. Prescriber of Ivermectin and HCQ]( [SPECIAL REPORTS]( [Expanding ICD Codes May Aid Rare Disease Patients, Research]( [ONCOLOGY/HEMATOLOGY]( [Possible Role for Ipilimumab in Metastatic Bladder Cancer, Study Suggests]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Navigating the Latest Evidence on Multi-Cancer Early Detection Technologies]( [SPECIAL REPORTS]( [Respiratory Therapist Charged With Murder; Clinic Implanted Embryo With Cancer Gene?]( [MEETING COVERAGE]( [Very Low-Dose OIT Shows Efficacy for Peanut-Allergic Kids]( THE BREAK ROOM [Play Today’s Wordosis]( ADVERTISEMENT [PAIN MANAGEMENT]( [Cancer-Free Medicare Recipients Received Fentanyl Indicated for Cancer Pain]( CME SPOTLIGHT [Transforming Patient-Centered Care for HR+/HER2- Breast Cancer Patients Through Collaborative Learning: A Toolkit for Clinical Teams]( [MEDICAL JOURNEYS]( [Staging of Urothelial Cancer: Cystoscopy and CT Evaluation Remain Standard]( [ASCO READING ROOM]( [Jonathan Rosenberg, MD, on Durvalumab Plus Olaparib in Metastatic Urothelial Cancer]( [MEDICAL JOURNEYS]( [For Your Patients: Staging Urothelial Cancer]( CME SPOTLIGHT [Advancing Collaboration Across the Multiple Myeloma Treatment Journey]( [ASCO READING ROOM]( [Synergy Between PARP inhibitors and Immunotherapy in Advanced Urothelial Cancer]( [INFECTIOUS DISEASE]( [CDC Offers Tentative Guidance for Severe Mpox Treatment]( [NEPHROLOGY]( [Cough Syrup Likely Culprit in Dozens of Child Deaths in Gambia, Says CDC]( CME SPOTLIGHT [Navigating PNH Recognition, Diagnosis, and Treatment]( [OPINION]( [Will Electronic Messaging Push Us Toward Concierge Medicine?]( [MEETING COVERAGE]( [The Current State of Muscle-Invasive Bladder Cancer Management]( CME SPOTLIGHT [Navigating the Rapidly Evolving DLBCL Treatment Landscape to Deliver Quality Care]( CME SPOTLIGHT [Immunotherapy in Advanced Melanoma: Evidence-Based Adverse Event Management Strategies to Improve Patient Outcomes]( # Weekly Survey [Is Private Equity Good for Medicine?]( Private equity firms are now acquiring [cardiology practices]( after years of deals with dermatology, gastroenterology, and other specialties[VOTE >]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Daily_DHE?xid=nl_mpt_DHE_2023-03-02&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

31/05/2024

Sent On

31/05/2024

Sent On

31/05/2024

Sent On

31/05/2024

Sent On

30/05/2024

Sent On

30/05/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.